09:15 , Jul 9, 2019 |  BC Extra  |  Financial News

BioNTech broadens investor base with $325M B round

While BioNTech remains quiet about a timeline for a potential listing, the German biotech has further broadened its investor base with multiple Asia-Pacific firms backing a $325 million series B round as it invests in...
18:35 , Jun 22, 2018 |  BC Week In Review  |  Financial News

Stealth to start Phase IIb of AMD candidate with $100M financing

Stealth BioTherapeutics Inc. (Newton, Mass.) raised $100 million June 18 through two convertible note rounds led by Nan Fung Technology's Pivotal Beta and Morningside Ventures, respectively. Also participating were funds associated with Atlantis Investment Management,...
22:08 , Jun 18, 2018 |  BC Extra  |  Financial News

Stealth to start Phase IIb of AMD candidate with $100M financing

Stealth BioTherapeutics Inc. (Newton, Mass.) raised $100 million Monday through two convertible note rounds led by Nan Fung Technology's Pivotal Beta. Also participating were funds associated with Atlantis Investment Management, BVCF Management, CMBC Capital Holdings,...
19:47 , Dec 8, 2017 |  BC Extra  |  Financial News

Tasly unit invests $50M in Chinese diabetes play Genova

Genova Biotech Co. Ltd. (Changzhou, China) received a $50 million investment from an undisclosed subsidiary of Tasly Holdings Group Co. Ltd. (Shanghai:600535). According to Genova financial advisor China Renaissance, the investment is part of Genova’s...
04:18 , Dec 8, 2017 |  BC Week In Review  |  Financial News

Anti-infectives company MicuRx raises RMB100M

MicuRx Pharmaceuticals Inc. (Hayward, Calif.) raised RMB100 million ($15.1 million) on Dec. 6 in a private placement led by existing investors Delian Capital and BVCF. The biotech's lead candidates are contezolid (MRX-1) and contezolid acefosamil...
21:03 , Dec 6, 2017 |  BC Extra  |  Financial News

Anti-infectives company MicuRx raises RMB100M

MicuRx Pharmaceuticals Inc. (Hayward, Calif.) raised RMB100 million ($15.1 million) in a private placement led by existing investors Delian Capital and BVCF. The biotech's lead candidates are contezolid (MRX-1) and contezolid acefosamil (MRX-4). MRX-1 is...
02:14 , Jan 26, 2016 |  BC Extra  |  Financial News

Chinese CAR-T play CARsgen raises $30M

CARsgen Therapeutics Co. Ltd. (Shanghai, China) raised $30 million in a series B round led by KTB Ventures and Jolly Innovation Ventures. Kaitai Capital and JIC GenesisFountain Healthcare Ventures also participated. CARsgen is developing chimeric...
08:00 , Jan 19, 2015 |  BC Week In Review  |  Company News

DiaCarta board of directors update

DiaCarta Inc. , Hayward, Calif.   Business: Diagnostic, Supply/Service   Appointed: Weixin Xu, principal at BVCF  ...
08:00 , Jan 12, 2015 |  BC Week In Review  |  Financial News

DiaCarta completes venture financing

DiaCarta Inc. , Hayward, Calif.   Business: Diagnostic, Supply/Service   Date completed: 2015-01-09   Type: Venture financing   Raised: $8 million   Investor: BVCF  ...
08:00 , Dec 15, 2014 |  BioCentury  |  Finance

CAR T bet in China

BVCF typically invests in later-stage healthcare plays in China, but the PE firm's Zhi Yang said BVCF went out of its comfort zone by investing in a series A round in new cancer immunotherapy play...